Scalp cooling in breast cancer patients treated with docetaxel-cyclophosphamide: patient- and nurse-reported results.

Annemarie CoolbrandtA T'JonckK BlauwensE DejaegerPatrick Neven Kevin PunieK VancoilleHans P M W Wildiers

Published in: Breast cancer research and treatment (2021)

Scalp cooling is successful in preventing severe chemotherapy-induced alopecia in almost half of the patients with breast cancer treated with docetaxel 75 mg/m2- cyclophosphamide 600 mg/m2. Better understanding of the success rate of scalp cooling enables correct patient information and decision-making support.

Keyphrases

chemotherapy induced
decision making
case report
low dose
high dose
primary care
locally advanced
early onset
squamous cell carcinoma
healthcare
health information